Sai Life Sciences Limited

Sai Life Sciences reported Q2 FY27 revenue of ₹659 crore, a 23% YoY increase, with an EBITDA margin of 28%. The company incurred a capex of ₹621 crore in H1 FY27 and is on track for its full-year proj

Sai Life Sciences reported Q2 FY27 revenue growth of 23% YoY to ₹659 crore with EBITDA margin sustained at 28%. The company invested ₹621 crore in H1 FY27 capacity expansion as part of its ongoing str

Sai Life Sciences reported unaudited Q2 FY27 standalone net profit of ₹960.13 million, a 16% increase from ₹829.49 million in Q2 FY26. The Board approved the appointment of three new Senior Management